US Insurers Out of Step With IBD Treatment Guidelines

Source link :

TOPLINE: The vast majority of insurance companies require patients with Crohn’s disease and ulcerative colitis to fail conventional treatment with steroids and immunomodulators before starting biologic therapy, despite guidance to the contrary. METHODOLOGY: Treatment of moderate to severe IBD has transitioned from step-up therapy to first-line use of a biologic agent for the induction of […]

Author : News Health

Publish date : 2024-03-14 07:12:01

Copyright for syndicated content belongs to the linked Source.